SPERO THERAPEUTICS INC (SPRO:NASDAQ)
$2.1 -0.02 (-0.9434%)
Analysed SPERO THERAPEUTICS INC (SPRO:NASDAQ) News Sources
Inventiva Builds Up Leadership Team Ahead of Potential Commercialization
22-04-2026
yahoo.com
Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
13-05-2026
yahoo.com
Promising Penny Stocks To Consider In May 2026
15-05-2026
yahoo.com
Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
17-06-2026
yahoo.com
Spero Shares Jump After FDA Clears First Oral Carbapenem Antibiotic for U.S. Market (SPRO)
18-06-2026
advfn.com
GSK, Spero Win FDA Nod For First-Ever Oral Carbapenem Antibiotic For Complicated UTIs
21-06-2026
yahoo.com
Is GSK plc (GSK) Expanding Its Anti-Infectives Leadership With New FDA-Approved Therapy?
24-06-2026
yahoo.com
GSK (LSE:GSK) Wins FDA Approval For Utebzi As Momelotinib Gains Orphan Tag
26-06-2026
yahoo.com
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
29-06-2026
yahoo.com
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
08-07-2026
yahoo.com
What is the current price of SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The current price of SPERO THERAPEUTICS INC (SPRO:NASDAQ) is $2.1.
SPERO THERAPEUTICS INC (SPRO:NASDAQ) absolute price change since previous trading day?
The absolute price change of SPERO THERAPEUTICS INC (SPRO:NASDAQ) since the previous trading day is $-0.02.
SPERO THERAPEUTICS INC (SPRO:NASDAQ) percentage price change since previous trading day?
The percentage price change of SPERO THERAPEUTICS INC (SPRO:NASDAQ) since the previous trading day is -0.9434%.
What is the most recent average sentiment score for SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The most recent average sentiment score for SPERO THERAPEUTICS INC (SPRO:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The most recent sentiment for SPERO THERAPEUTICS INC (SPRO:NASDAQ) is .
SEC-8K** Filing Available For SPERO THERAPEUTICS INC (SPRO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.